Method Article

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

DOI:

10.3791/56583

December 11th, 2017

In This Article

Summary

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

This is a time- and cost-effective in vitro protocol investigating the mechanisms of acquired resistance to targeted therapeutic agents, which is a highly unmet medical need in cancer management.

Abstract

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The past two decades have seen a shift from cytotoxic drugs to targeted therapy in medical oncology. Although targeted therapeutic agents have shown more impressive clinical efficacy and minimized adverse effects than traditional treatments, drug resistance has become the main limitation to their benefits. Several preclinical in vitro/in vivo models of acquired resistance to targeted agents in clinical practice have been developed mainly by using two strategies: i) genetic manipulation for modeling genotypes of acquired resistance, and ii) in vitro/in vivo selection of resistant models. In the present work, we propose a unifying framework, for investigating the underlying mechanisms responsible for acquired resistance to targeted therapeutic agents, starting from the generation of drug-resistant cellular subclones to the description of silencing procedures used for restoring the sensitivity to the inhibitor. This simple time- and cost-effective approach is widely applicable, and could be easily extended to investigate resistance mechanisms to other targeted therapeutic drugs in different tumor histotypes.

Introduction

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Following up on the crucial discoveries in molecular and cellular biology, a number of novel synthesized anticancer molecules have been developed to selectively target oncogenic signaling pathways in a broad array of tumor types. In particular, two categories of targeted therapeutic agents with unique properties in oncology, namely synthetic chemical compounds and recombinant monoclonal antibodies, are known to have achieved clinical successes and dramatically altered cancer care in recent decades1,2,3.

Nevertheless, despite their impressive initia....

Access restricted. Please log in or start a trial to view this content.

Protocol

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

NOTE: This protocol has been specifically adjusted for the analysis of the mechanisms underlying acquired resistance to trastuzumab of HER-positive gastric cancer cell lines. All laboratory instruments needed are reported in the Table of Materials.

1. Generation of Targeted Therapy Resistant Subclones

NOTE: This is the most critical and difficult to standardize step in the protocol due to the fact that different cell lines may exhibit different sensitivities to the targeted therapeutic inhibitor independently from their tumor histotype or drug concentration used.

  1. Culture NCI-N87 cell ....

Access restricted. Please log in or start a trial to view this content.

Results

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Figure 1 outlines the framework of the experimental procedure. Three gastric cancer cell-lines expressing a high level of HER2 and sensitive to trastuzumab (IC50 < peak plasma level of drug, Figure 2A, left graph) were grown in culture medium containing the targeted therapeutic agent. A dose 10-fold lower than the peak plasma concentration of trastuzumab (10 µg/mL) was set as the starting dose, and gradually increas.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

While personalized and targeted therapies have elicited growing enthusiasm, these so-called 'smart' therapies face the same major hurdle as traditional chemotherapy drugs, i.e., the rapid and unpredictable acquisition of drug resistance. To improve the results of targeted therapy, drug-resistance problems must be solved through a better understanding of the mechanisms that cause them. Here, we presented a widely accessible in vitro methodology to investigate the mechanisms of acquired resistance.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The authors have nothing to disclose.

Acknowledgements

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The authors wish to thank Dr. Veronica Zanoni for editing the manuscript.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Trizol ReagentInvitrogen15596026TRIzol Reagent is a reagent for isolating high-quality total RNA or simultaneously isolating RNA, DNA, and protein from a variety of biological samples
ISCRIPT CDNA SYNTHESIS KITBio-Rad1708891The iScript cDNA synthesis kit is a sensitive and easy-to-use first-strand cDNA synthesis kit for gene expression analysis using real-time qPCR.
TaqMan gene expression assayLife Technologies4331182Applied Biosystems TaqMan Gene Expression Assays consist of a pair of unlabeled PCR primers and a TaqMan probe with an Applied Biosystems FAM or VIC dye label on the 5’ end and minor groove binder (MGB) and nonfluorescent quencher (NFQ) on the 3’ end.
M-PER Mammalian Protein Extraction ReagentThermo Scientific78501Thermo Scientific M-PER Mammalian Protein Extraction Reagent is designed to provide highly efficient total soluble protein extraction from cultured mammalian cells.
Halt Protease and Phosphatase Inhibitor Cocktail (100X)Thermo Scientific78440Thermo Scientific Halt Protease and Phosphatase Inhibitor Cocktail (100X) provides the convenience of a single solution with full protein sample protection for cell and tissue lysates.
Pierce BCA Protein Assay KitThermo Scientific23225The Thermo Scientific Pierce BCA Protein Assay Kit is a two-component, high-precision, detergent-compatible assay reagent set to measure (A562nm) total protein concentration compared to a protein standard.
4x Laemmli Sample BufferBio-Rad1610747Use 4x Laemmli Sample Buffer for preparation of samples for SDS PAGE. For reduction of samples, add a reducing agent such as 2-mercaptoethanol to the buffer prior to mixing with the sample.
4–20% Mini-PROTEAN TGX Precast Protein GelsBio-Rad456-1094Long-life TGX (Tris-Glycine eXtended) Gels have a novel formulation and can be used for both standard denaturing protein separations as well as native electrophoresis.
Precision Plus Protein WesternC Blotting StandardsBio-Rad1610376Precision Plus Protein Prestained Standards are available in Dual Color, All Blue, Kaleidoscope, and Dual Xtra formats. All four have the same gel migration patterns, with 3 high-intensity reference bands (25, 50, and 75 kD).
10x Tris/Glycine/SDSBio-Rad161073210x Tris/glycine/SDS is a premixed running buffer for separating protein samples by SDS-PAGE.
Trans-Blot Turbo Mini PVDF Transfer PacksBio-Rad1704156Trans-Blot Turbo Mini PVDF Transfer Packs for fast, efficient transfer of proteins from mini gels using the Trans-Blot Turbo Transfer System. Each vacuum sealed, ready-to-use transfer pack contains two buffer-saturated ion reservoir stacks and a prewetted PVDF membrane.
Precision Protein StrepTactin-HRP ConjugateBio-Rad1610381StrepTactin-Horseradish Peroxidase (HRP) Conjugate for chemiluminescent or colorimetric detection of Precision Plus Protein Unstained Protein Standards or Precision Plus Protein WesternC Protein Standards on western blots.
Immun-Star WesternC solutionBio-Rad5572Immun-Star WesternC solution, a method of protein detection , detects mid-femtogram amounts of protein.
Universal Negative ControlInvitrogen12935300Negative Control siRNA has no significant sequence similarity to mouse, rat, or human gene sequences. The control has also been tested in cell-based screens and proven to have no significant effect on cell proliferation, viability, or morphology.
opti-MEM Glutamax MediumThermo Fisher Scientific51985026Opti-MEM Medium is an improved Minimal Essential Medium (MEM) that allows for a reduction of Fetal Bovine Serum supplementation by at least 50% with no change in growth rate or morphology.
Silencer Select Pre-Designed & Validated siRNAAmbion4390824RNA interference (RNAi) is the best way to effectively knock down gene expression to study protein function in a wide range of cell types.
Lipofectamine RNAiMAX Transfection ReagentInvitrogen13778075Lipofectamine RNAiMAX Transfection Reagent offers an advanced, efficient solution for siRNA delivery. No other siRNA specific transfection reagent provides such easy and efficient siRNA delivery in a wide variety of cell lines including common cell types, stem cells and primary cells, as well as traditionally hard-to-transfect cell types.
Mouse anti-IQGAP1Invitrigen33-8900working concentration: 1:400 in 5% milk solution
goat anti-mouse IgG-HRP: sc-2005Santa Cruzsc-2005working concentration: 1:10000 in 5% milk solution
PMSFSigma AldrichP 7626this is an inhibitor of serine proteases and acetylcholinesterase
Thermocycler for RT-PCRMJ ResearchMJ Research PTC-200 Thermal Cyclerit allows temperature homogeneity and a ramping speed of up to 3°C/sec. The protocol can be performed also with other thermalcyclers
Real Time RT-PCR instrumentApplied Biosystems7500 RT-PCR systemThis is a five-color platform that uses fluorescence-based polymerase chain reaction (PCR) reagents to provide a relative quantification using comparative CT assay type. The protocol can be performed also with other thermalcyclers
Microvolume SpectrophotometersThermo ScientificNanodropIt provides an accurate and fast acid nucleid measurement using little volume of sample
Blotting systemBio-RadTrans-Blot Turbo systemIt perfoms a semy-dry transfer in a few minutes
Image acquisition system and gel documentationBio-RadChemidoc image systemIt is easy to use for chemiluminescent detection

References

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,
  1. Gerber, D. E. Targeted therapies: a new generation of cancer treatments. Am Fam Physician. 77 (3), 311-319 (2008).
  2. Zhang, J., Yang, P. L., Gray, N. S. Targeting cancer with small molecule kinase inhibitors. Nat Rev Cancer. 9 (1), 28-39 (2009).
  3. Nelson, A. L., ....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Tags

Drug ResistanceTrastuzumab ResistanceHER2 PositiveIC50 RatioIQGAP1 SilencingClonogenic AssayCell Culture

Related Articles